Skip to content
VC FundPuts its own capital into companiesActive · deal in last 18 monthsLAST VERIFIED Oct 2026 · 10 SOURCES

Noso Capital

Also known as Noso Capital, SGEIC, S.A., NOSO CAPITAL SGEIC, S.A.

Santiago de Compostela VC manager investing at seed and Series A–B in Spanish and European tech companies with social impact; funds Noso Capital I, Bio & Tech Smart Capital, Subgen Ventures.

HEADQUARTERS
Santiago de Compostela, Spain
FOUNDED
—
AUM
—
OUTSIDE CAPITAL
Yes
TEAM LISTED
7 people

Focus

STAGES
SeedSeries ASeries B
SECTORS
HealthTechBiotech & Life SciencesMobility & LogisticsArtificial Intelligence
ASSET MIX
Venture capitalImpact
GEOGRAPHY
SpainPortugalEurope

Overview

Noso Capital, SGEIC, S.A. is an independent manager registered with the CNMV (no. 149, September 2019) and based in Santiago de Compostela. It invests in technology-based companies with product-market fit at seed and Series A–B in sectors with positive social impact, mainly in Spain, Portugal and Europe. It manages Noso Capital I, FCRE (€30M target) and Bio & Tech Smart Capital, FCRE (life sciences, €30M target, €50M hard cap), plus Subgen Ventures Capital I, FCRE, registered in 2025.

Investment thesis

Seed and Series A–B companies with proven product-market fit using AI, IoT, blockchain, VR/AR or robotics in B2B/B2C2B models. Noso Capital I: social impact, industrial and business services, leisure and lifestyle (secondary: life sciences), Spain and Portugal. Bio & Tech Smart Capital: life sciences in Spain, Europe and the US.

PORTFOLIO (6)

  • Pharmacelera
    Biotech & Life Sciences · since 2026
  • Velca
    Mobility & Logistics · since 2023
  • Zerintia HealthTech
    HealthTech · since 2023
  • Oncostellae
    Biotech & Life Sciences · since 2023
  • Adntro Genetics
    Biotech & Life Sciences · since 2024
  • Healthplus.ai
    HealthTech · since 2026

People

  • Antonio Couceiro
    Founding Partner & Chairman · source
  • Tomás Pérez
    General Partner · source
  • Vicente Espert
    Operating Partner · source
  • Bernardo Cebolla
    Operating Partner · source
  • Pedro Pajarrón
    Operating Partner · source
  • Pilar Matute
    Investment Manager · source
  • María Lobelle
    Investor Relations · source

Links

Frequently asked questions

Noso Capital is a VC fund based in Santiago de Compostela, Spain.

Yes. Noso Capital invests its own capital in private companies.

Noso Capital invests at Seed, Series A and Series B stages in HealthTech, Biotech & Life Sciences, Mobility & Logistics and Artificial Intelligence.

Key people at Noso Capital include Antonio Couceiro (Founding Partner & Chairman), Tomás Pérez (General Partner), Vicente Espert (Operating Partner) and Bernardo Cebolla (Operating Partner).

Noso Capital's investments include Pharmacelera, Velca, Zerintia HealthTech, Oncostellae, Adntro Genetics and Healthplus.ai.

The most recent publicly reported investment by Noso Capital is Healthplus.ai, announced in Apr 2026.

Yes. Noso Capital manages capital from outside investors.